The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor.
Kevin X LiuNatalie B CollinsKatie A GreenzangElissa FurutaniKevin CampbellAndrew GrovesElizabeth A MullenSuzanne ShustermanJennifer SpidleKaren J MarcusBrent R WeilChristopher B WeldonA Lindsay FrazierKatherine A JanewayAllison F O'NeillJennifer W MackSteven G DuBoisDavid S ShulmanPublished in: Pediatric blood & cancer (2020)
The addition of VIT to interval-compressed chemotherapy is tolerable and active in DSRCT, with activity warranting additional investigation.